{"id":"https://openalex.org/W4286294612","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562","title":"Evaluation of formulation-associated ifosfamide neurotoxicity.","display_name":"Evaluation of formulation-associated ifosfamide neurotoxicity.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286294612","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e23562","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071013667","display_name":"Karin M Abernathy","orcid":"https://orcid.org/0000-0002-5669-1803","observed_orcids":["https://orcid.org/0000-0002-5669-1803"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Abernathy","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061581171","display_name":"Colleen McCabe","orcid":"https://orcid.org/0000-0001-8309-5196","observed_orcids":["https://orcid.org/0000-0001-8309-5196"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen McCabe","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089904669","display_name":"Matthew Perciavalle","orcid":"https://orcid.org/0000-0003-4572-9906","observed_orcids":["https://orcid.org/0000-0003-4572-9906"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Perciavalle","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024172668","display_name":"Manuel Cortez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manuel Cortez","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ryan Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Miller","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029735639","display_name":"Bradley J. Yelvington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Yelvington","raw_affiliation_strings":["Vanderbilt Univ. Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Univ. Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087055974","display_name":"Vicki Leigh Keedy","orcid":"https://orcid.org/0000-0002-7213-7562","observed_orcids":["https://orcid.org/0000-0002-7213-7562"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vicki Leigh Keedy","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068498659","display_name":"Elizabeth J. Davis","orcid":"https://orcid.org/0000-0001-7626-2435","observed_orcids":["https://orcid.org/0000-0001-7626-2435"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Davis","raw_affiliation_strings":["Vanderbilt University, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e23562","last_page":"e23562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13077","display_name":"Cancer-related cognitive impairment studies","score":0.0617000013589859,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9769999980926514},{"id":"https://openalex.org/keywords/encephalopathy","display_name":"encephalopathy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.675000011920929},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.8109999895095825},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.6060000061988831},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7450000047683716},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.9766339063644409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8695299625396729},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.7350375056266785},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5841717720031738},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.46857333183288574},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4492708742618561},{"id":"https://openalex.org/C2778621155","wikidata":"https://www.wikidata.org/wiki/Q576349","display_name":"Encephalopathy","level":2,"score":0.442754864692688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39726755023002625},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33180806040763855},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2685272693634033},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.24340948462486267},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e23562","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e23562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2061728971","https://openalex.org/W7165695817","https://openalex.org/W2148385908","https://openalex.org/W2198025069","https://openalex.org/W2319608606","https://openalex.org/W2143043636","https://openalex.org/W2314749318","https://openalex.org/W2061394911","https://openalex.org/W2025195447","https://openalex.org/W3092196006"],"abstract_inverted_index":{"e23562":[0],"Background:":[1],"Ifosfamide,":[2],"an":[3],"alkylating":[4],"agent":[5],"used":[6],"commonly":[7],"in":[8,69,127,173],"both":[9,25],"hematologic":[10],"and":[11,30,138,166,168,195,216,219],"solid":[12],"tumor":[13],"malignancies,":[14],"carries":[15],"a":[16,26,31,82],"notable":[17],"risk":[18,113,199,254],"for":[19,33,115,144,189,201,248,256],"neurotoxicity/encephalopathy.":[20],"Ifosfamide":[21],"is":[22,259],"available":[23,74,95],"as":[24],"reconstituted":[27,54,135,179,241],"powder":[28,136,180,242],"formulation":[29,97,137,146,181,243],"solution":[32,50,143,188,247],"injection.":[34,249],"Literature":[35],"has":[36],"shown":[37],"that":[38],"there":[39],"may":[40],"be":[41],"higher":[42],"rates":[43,66,236],"of":[44,59,67,77,85,93,98,106,117,147,159,163,197,203,210,237],"ifosfamide":[45,160,213,232],"neurotoxicity/encephalopathy":[46,68],"(INT/E)":[47],"with":[48,71,130,231,239],"the":[49,53,65,72,104,128,134,142,154,178,187,208,240,246],"compared":[51,244],"to":[52,63,245],"powder.":[55],"The":[56,100],"primary":[57,101],"objective":[58],"this":[60,224],"study":[61,84,129],"was":[62,103],"compare":[64],"association":[70],"two":[73,155],"pharmaceutical":[75,96],"formulations":[76],"ifosfamide.":[78,99,148],"Methods:":[79],"We":[80],"performed":[81],"retrospective":[83],"adult":[86],"patients":[87,122,132,140,175,184,227],"receiving":[88,133,141,177,186],"at":[89],"least":[90],"one":[91],"dose":[92,158],"either":[94],"outcome":[102],"incidence":[105],"formulation-associated":[107],"INT/E.":[108,118],"Secondary":[109],"outcomes":[110],"included":[111,126],"additional":[112,198,253],"factors":[114,200,255],"development":[116,202,258],"Results:":[119],"Of":[120],"218":[121],"evaluated,":[123],"212":[124],"were":[125,151,229],"56":[131],"156":[139],"injection":[145,190],"Baseline":[149],"characteristics":[150],"similar":[152],"between":[153],"groups,":[156],"including":[157,207],"received,":[161],"use":[162],"INT/E":[164,171,204,238,257],"prophylaxis,":[165],"renal":[167,215],"hepatic":[169,217],"function.":[170],"occurred":[172],"4":[174],"(7.1%)":[176],"vs":[182],"32":[183],"(20.5%)":[185],"(p":[191],"=":[192],"0.022)":[193],"Evaluation":[194],"analysis":[196,251],"are":[205],"ongoing,":[206],"impact":[209],"baseline":[211],"demographics,":[212],"dosing,":[214],"function,":[218],"concomitant":[220],"medications.":[221],"Conclusions:":[222],"In":[223],"study,":[225],"hematology/oncology":[226],"who":[228],"treated":[230],"had":[233],"significantly":[234],"lower":[235],"Further":[250],"regarding":[252],"ongoing.[Table:":[260],"see":[261],"text]":[262]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-07-21T00:00:00"}